X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

BIIB

Closed

Biogen Inc

130.07
+4.48 (+3.57%)
Last Update: 01 Jul 2025 23:16:00
Yesterday: 125.59
Day's Range: 124.935 - 134.75
Send
When Written:
 
278.03
Biogen Inc. is a biotechnology company that specializes in the discovery, development, and commercialization of therapies for neurological, autoimmune, and hematologic disorders. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.

Biogen's portfolio includes several drugs that are used to treat multiple sclerosis, spinal muscular atrophy, and hemophilia, among other conditions. The company is also working on developing therapies for Alzheimer's disease, Parkinson's disease, and other neurological disorders.

In addition to its research and development efforts, Biogen has a strong presence in the global biotech industry, with operations in North America, Europe, and Asia. The company employs more than 7,000 people worldwide and has a market capitalization of over $50 billion.

Biogen has been recognized for its commitment to sustainability and corporate responsibility, and has received numerous awards for its efforts in these areas. The company is also actively involved in philanthropic initiatives, including supporting research and patient advocacy organizations.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.209
X